LUNG Research and Charts

LUNG - Pulmonx Corp Ordinary Shares (Healthcare: Medical Devices)

Projected Earnings Date: 2024-05-22 (Delayed quote data 2026-02-10)

Last 1.45	Change ⇓ -0.09 (-5.84%)	Volume 347,427
	Open 1.54	High 1.56	Low 1.45

8EMA (Daily) 1.55	40EMA (Daily) 1.83	50EMA (Daily) 1.86	STO (Daily) 7.977	MACD Hist (Daily) -0.004
8EMA (Weekly) 1.743	40EMA (Weekly) 2.60	50EMA (Weekly) 3.00	STO (Weekly) 21.724	MACD Hist (Weekly) -0.046


Company Profile
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.